DIA is hosting a meeting to explore the topic of diversity, equity, and inclusion in the drug development life cycle. The meeting will include interactive and compelling discussions and exercises that will lead to a better understanding of how the drug development sector can improve and encourage accountability and sustainability of efforts. An important purpose of the meeting is to advance dialogue among thought leaders from industry, clinical research sites, patient engagement, academia, FDA, and public policy to spur additional ideas to move the field forward.
The meeting will take place virtually on Tuesday, April 27 from 10am-5:45pm EDT. A keynote address will be delivered by Robert Fullilove, EdD of Columbia University and a full agenda of speakers is available here.
The meeting does require a significant fee to register with discounts for those working for non-profits, academia, and government. Registration is open now!
Comments